IE 11 is a very old Browser and it`s not supported on this site

Consolidated statement of changes in equity for the year ended December 31

in CHF 1 000

Share capital

Treasury shares

Retained earnings

Total

Balances at January 1, 2022

11 080

(9 205)

3 281 618

3 283 493

Dividend

(212 242)

(212 242)

Trade with treasury shares

(27 303)

(27 303)

Total comprehensive income for the period

(357 812)

(357 812)

Balances at December 31, 2022

11 080

(36 508)

2 711 563

2 686 135

Balances at January 1, 2023

11 080

(36 508)

2 711 563

2 686 135

Dividend

(156 311)

(156 311)

Total comprehensive income for the period

(206 607)

(206 607)

Balances at December 31, 2023

11 080

(36 508)

2 348 645

2 323 217

The notes are an integral part of the consolidated financial statements.

BB Biotech AG uses cookies to improve website usability and ensure the best possible user experience. Use of cookies & disclaimer